CONJUPRI FDA approval date
The FDA approved CONJUPRI on 19 Dec 2019.
- FDA approval date
- 19 Dec 2019
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as LEVAMLODIPINE MALEATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2019-12-19Day | CONJUPRI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA212895", "applicant_as_listed_by_fda": "CSPC OUYI", "brand_names": ["CONJUPRI"], "active_ingredients": ["LEVAMLODIPINE MALEATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191219", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |